• Return to Headlines

Shares of EPZM Down 49.2% Since Downtrend Call on Shares

By Amy Schwartz

SmarTrend identified a Downtrend for Epizyme Inc (NASDAQ:EPZM) on June 15th, 2018 at $15.43. In approximately 5 months, Epizyme Inc has returned 49.17% as of today's recent price of $7.84.

In the past 52 weeks, shares of Epizyme Inc have traded between a low of $7.41 and a high of $21.40 and are now at $7.84, which is 6% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.9% while the 50-day MA has declined 2.5%.

Epizyme, Inc. develops and discovers therapeutics for the treatment of cancer. The Company provides small molecule inhibitors for patients with genetically defined cancers and inflammatory, metabolic, and neurodegenerative diseases. Epizyme operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Epizyme Inc.

Log in and add Epizyme Inc (EPZM) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights epizyme inc

Ticker(s): EPZM